Related Experiment Video

Updated: Aug 14, 2026

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay
15:32

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay

Published on: August 5, 2011

Arterial homeostasis, inflammation, and erythropoietic growth factors

Pascal J Goldschmidt-Clermont1, Anna Mae Diehl

  • 1Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Reviews in Cardiovascular Medicine
|December 13, 2005
PubMed

Insights

Kidneys may promote cardiovascular repair by stimulating bone marrow to produce vascular progenitor cells. Therapies like recombinant human erythropoietin enhance these cells, aiding tissue healing in chronic heart diseases.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Regenerative Medicine

Background:

  • A neurohumoral connection between kidneys and heart is known, especially in hypertension and cardiomyopathy.
  • A theoretical pathway involves kidney-derived growth factors stimulating bone marrow to produce vascular progenitor cells for cardiovascular repair.

Purpose of the Study:

  • To explore the role of kidney-produced growth factors in bone marrow regeneration of vascular progenitor cells.
  • To examine medical therapies, such as recombinant human erythropoietin, that enhance endothelial progenitor cell function and promote cardiovascular tissue repair.

Main Methods:

  • Review of existing literature on the kidney-heart axis and progenitor cell biology.
  • Analysis of studies investigating the effects of specific medical therapies on endothelial progenitor cells and tissue healing.

Main Results:

  • Kidney-derived factors may induce bone marrow to release vascular progenitor cells.
  • Recombinant human erythropoietin has demonstrated potential in improving endothelial progenitor cell function and survival.
  • Therapeutic enhancement of progenitor cells shows promise for healing damaged cardiovascular tissue.

Conclusions:

  • Focusing on tissue repair mechanisms, rather than solely injury prevention, may be crucial for managing chronic heart diseases.
  • Stimulating the body's natural repair processes via progenitor cell enhancement offers a potential therapeutic strategy for cardiovascular conditions.

More Related Videos

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...